These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

535 related articles for article (PubMed ID: 30124878)

  • 1. Delay Aversion and Executive Functioning in Adults With Attention-Deficit/Hyperactivity Disorder: Before and After Stimulant Treatment.
    Low AM; le Sommer J; Vangkilde S; Fagerlund B; Glenthøj B; Sonuga-Barke E; Habekost T; Jepsen JRM
    Int J Neuropsychopharmacol; 2018 Nov; 21(11):997-1006. PubMed ID: 30124878
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Visual attention in adults with attention-deficit/hyperactivity disorder before and after stimulant treatment.
    Low AM; Vangkilde S; le Sommer J; Fagerlund B; Glenthøj B; Jepsen JRM; Bundesen C; Petersen A; Habekost T
    Psychol Med; 2019 Nov; 49(15):2617-2625. PubMed ID: 30560740
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cognitive heterogeneity in adult attention deficit/hyperactivity disorder: A systematic analysis of neuropsychological measurements.
    Mostert JC; Onnink AMH; Klein M; Dammers J; Harneit A; Schulten T; van Hulzen KJE; Kan CC; Slaats-Willemse D; Buitelaar JK; Franke B; Hoogman M
    Eur Neuropsychopharmacol; 2015 Nov; 25(11):2062-2074. PubMed ID: 26336867
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Executive function and attention deficit hyperactivity disorder: stimulant medication and better executive function performance in children.
    Kempton S; Vance A; Maruff P; Luk E; Costin J; Pantelis C
    Psychol Med; 1999 May; 29(3):527-38. PubMed ID: 10405075
    [TBL] [Abstract][Full Text] [Related]  

  • 5. OROS-methylphenidate efficacy on specific executive functioning deficits in adults with ADHD: a randomized, placebo-controlled cross-over study.
    Bron TI; Bijlenga D; Boonstra AM; Breuk M; Pardoen WF; Beekman AT; Kooij JJ
    Eur Neuropsychopharmacol; 2014 Apr; 24(4):519-28. PubMed ID: 24508533
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Parent-Reported Improvements in Family Functioning in a Randomized Controlled Trial of Lisdexamfetamine for Treatment of Parental Attention-Deficit/Hyperactivity Disorder.
    Babinski DE; Waxmonsky JG; Waschbusch DA; Humphery H; Pelham WE
    J Child Adolesc Psychopharmacol; 2017 Apr; 27(3):250-257. PubMed ID: 27991835
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effects of Atomoxetine and Osmotic Release Oral System-Methylphenidate on Executive Functions in Patients with Combined Type Attention-Deficit/Hyperactivity Disorder.
    Ince Tasdelen B; Karakaya E; Oztop DB
    J Child Adolesc Psychopharmacol; 2015 Aug; 25(6):494-500. PubMed ID: 26218871
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effects of methylphenidate on cognitive functions in boys with attention deficit hyperactivity disorder: Does baseline performance matter?
    Idema IME; Payne JM; Coghill D
    J Consult Clin Psychol; 2021 Jul; 89(7):615-625. PubMed ID: 34383534
    [No Abstract]   [Full Text] [Related]  

  • 9. Empathy and Facial Expression Recognition in Children With and Without Attention-Deficit/Hyperactivity Disorder: Effects of Stimulant Medication on Empathic Skills in Children with Attention-Deficit/Hyperactivity Disorder.
    Gumustas F; Yilmaz I; Yulaf Y; Gokce S; Sabuncuoglu O
    J Child Adolesc Psychopharmacol; 2017 Jun; 27(5):433-439. PubMed ID: 28332851
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A head-to-head randomized clinical trial of methylphenidate and atomoxetine treatment for executive function in adults with attention-deficit hyperactivity disorder.
    Ni HC; Shang CY; Gau SS; Lin YJ; Huang HC; Yang LK
    Int J Neuropsychopharmacol; 2013 Oct; 16(9):1959-73. PubMed ID: 23672818
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Does OROS-methylphenidate improve core symptoms and deficits in executive function? Results of an open-label trial in adults with attention deficit hyperactivity disorder.
    Fallu A; Richard C; Prinzo R; Binder C
    Curr Med Res Opin; 2006 Dec; 22(12):2557-66. PubMed ID: 17166338
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Processing speed can monitor stimulant-medication effects in adults with attention deficit disorder with hyperactivity.
    Nielsen NP; Wiig EH; Bäck S; Gustafsson J
    Nord J Psychiatry; 2017 May; 71(4):296-303. PubMed ID: 28413936
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Lisdexamfetamine dimesylate in adults with attention-deficit/ hyperactivity disorder who report clinically significant impairment in executive function: results from a randomized, double-blind, placebo-controlled study.
    Adler LA; Dirks B; Deas PF; Raychaudhuri A; Dauphin MR; Lasser RA; Weisler RH
    J Clin Psychiatry; 2013 Jul; 74(7):694-702. PubMed ID: 23945447
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Acute neuropsychological effects of methylphenidate in stimulant drug-naïve boys with ADHD II--broader executive and non-executive domains.
    Rhodes SM; Coghill DR; Matthews K
    J Child Psychol Psychiatry; 2006 Nov; 47(11):1184-94. PubMed ID: 17076758
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Common and unique therapeutic mechanisms of stimulant and nonstimulant treatments for attention-deficit/hyperactivity disorder.
    Schulz KP; Fan J; Bédard AC; Clerkin SM; Ivanov I; Tang CY; Halperin JM; Newcorn JH
    Arch Gen Psychiatry; 2012 Sep; 69(9):952-61. PubMed ID: 22945622
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Supervised off-label prescribing of methylphenidate in adult ADHD].
    Carton L; Dondaine T; Deheul S; Marquié C; Brigadeau F; Amad A; Devos D; Danel T; Bordet R; Cottencin O; Gautier S; Ménard O
    Encephale; 2019 Feb; 45(1):74-81. PubMed ID: 30122296
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Examining relationships between executive functioning and delay aversion in attention deficit hyperactivity disorder.
    Karalunas SL; Huang-Pollock CL
    J Clin Child Adolesc Psychol; 2011; 40(6):837-47. PubMed ID: 22023275
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Attention-deficit/hyperactivity disorder (ADHD) symptoms, anxiety symptoms, and executive functioning in emerging adults.
    Jarrett MA
    Psychol Assess; 2016 Feb; 28(2):245-50. PubMed ID: 26121381
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Are stimulants effective in the treatment of executive function deficits? Results from a randomized double blind study of OROS-methylphenidate in adults with ADHD.
    Biederman J; Mick E; Fried R; Wilner N; Spencer TJ; Faraone SV
    Eur Neuropsychopharmacol; 2011 Jul; 21(7):508-15. PubMed ID: 21303732
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Neurocognitive performance and behavioral symptoms in patients with attention-deficit/hyperactivity disorder during twenty-four months of treatment with methylphenidate.
    Wang LJ; Chen CK; Huang YS
    J Child Adolesc Psychopharmacol; 2015 Apr; 25(3):246-53. PubMed ID: 25574708
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 27.